Cargando…
Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy
BACKGROUND: Dilated cardiomyopathy may be heritable but shows extensive genetic heterogeneity. The utility of whole exome sequencing as a first‐line genetic test for patients with dilated cardiomyopathy in a contemporary “real‐world” setting has not been specifically established. Using whole exome s...
Autores principales: | Ramchand, Jay, Wallis, Mathew, Macciocca, Ivan, Lynch, Elly, Farouque, Omar, Martyn, Melissa, Phelan, Dean, Chong, Belinda, Lockwood, Siobhan, Weintraub, Robert, Thompson, Tina, Trainer, Alison, Zentner, Dominica, Vohra, Jitendra, Chetrit, Michael, Hare, David L., James, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033851/ https://www.ncbi.nlm.nih.gov/pubmed/31931689 http://dx.doi.org/10.1161/JAHA.119.013346 |
Ejemplares similares
-
A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy
por: Catchpool, Max, et al.
Publicado: (2019) -
Emerging role of genetic analysis for stratification of sudden cardiac death risk in dilated cardiomyopathy: An illustrative case
por: Yao, Jessica Victoria, et al.
Publicado: (2020) -
Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy
por: Long, Pamela A., et al.
Publicado: (2017) -
Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
por: Ramchand, Jay, et al.
Publicado: (2018) -
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy
por: D’Agostino, Ylenia, et al.
Publicado: (2022)